Health

How Is Penumbra (NYSE:PEN) Expanding Its Medical Device Portfolio?

March 18, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Institutional investors, including Proficio Capital Partners LLC, have increased their stakes in Penumbra.,The company continues to maintain a strong financial position with a low debt-to-equity ratio.,Penumbra specializes in developing ad...

How Is Veracyte (NASDAQ:VCYT) Expanding Its Market in Genomic Testing?

March 18, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Victory Capital Management Inc. adjusted its holdings in Veracyte, reducing its position during the fourth quarter.,Jennison Associates LLC and other firms increased their stakes, showing active institutional participation.,Veracyte contin...

How Is Avantor (NYSE:AVTR) Managing Its Financial and Operational Strategy?

March 18, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,PNC Financial Services Group Inc. reduced its stake in Avantor, aligning with broader institutional trading activity.,State Street Corp and Janus Henderson Group PLC increased their holdings, contributing to overall market engagement.,Inst...

How Is HealthEquity (NASDAQ:HQY) Positioning Itself in the Financial Market?

March 18, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Institutional investors have adjusted their holdings in HealthEquity, reflecting market engagement.,Stock performance remains stable, maintaining structured participation within its sector.,Corporate transactions indicate shifts in financi...

How Are Financial Metrics Supporting Jazz Pharmaceuticals' (NASDAQ:JAZZ) Market Growth?

March 18, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Atria Investments Inc. significantly increased its stake in Jazz Pharmaceuticals during the fourth quarter.,UBS Asset Management Americas LLC and Centre Asset Management LLC also made substantial moves to adjust their holdings.,Jazz Pharma...

How Institutional Investors Are Boosting United Therapeutics (NASDAQ:UTHR) Market Position

March 18, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Raymond James Financial Inc. acquires a significant stake in United Therapeutics.,Institutional interest continues to grow with adjustments from Oregon Public Employees Retirement Fund and Wealth Enhancement Advisory Services LLC.,United T...

Why Are Institutional Investors Increasing Their Holdings in Encompass Health?

March 17, 2025 11:29 AM PDT| By Team Kalkine Media

Highlights,Institutional investors continue to adjust their holdings in Encompass Health, reflecting ongoing interest in the company.,Several major firms, including State Street Corp and Geode Capital Management, have recently expanded their position...

Why Are Institutional Investors Adjusting Their Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)?

March 17, 2025 11:15 AM PDT| By Team Kalkine Media

Headlines,Atria Investments Inc. reduced its stake in Pediatrix Medical Group by 3.5% during the fourth quarter.,Other institutional investors, including Pacer Advisors Inc. and Weiss Asset Management LP, have also modified their holdings in the comp...

Alkermes plc: Institutional Transactions and Market Developments

March 17, 2025 02:36 AM PDT| By Team Kalkine Media

Highlights:,Victory Capital Management adjusted its position in Alkermes plc, reducing its stake in the company.,Multiple institutional entities made changes to their shareholding structures, reflecting strategic portfolio adjustments.,Market perform...

How Is Tenet Healthcare (NYSE:THC) Expanding Its Healthcare Services?

March 17, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Institutional investors have made adjustments to their positions in Tenet Healthcare, reflecting evolving market engagement.,The company maintains a strong presence in the healthcare sector through hospital and ambulatory care services.,Te...

How Does Arcus Biosciences (NYSE:RCUS) Maintain Its Research Focus?

March 17, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Institutional investments in Arcus Biosciences have seen recent increases.,The company focuses on developing cancer therapies and advancing clinical trials.,Financial performance includes revenue generation and ongoing clinical-stage resea...

How Is Biohaven Ltd. (NYSE:BHVN) Supporting Its Clinical Trials?

March 17, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Institutional investments in Biohaven Ltd. have shown recent increases.,The company focuses on developing therapies in neuroscience, immunology, and oncology.,Research pipeline includes multiple clinical-stage drug candidates.,Biohaven Ltd...

McKesson Corporation (NYSE:MCK) Breaking Down Its Shareholder Composition

March 17, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,McKesson Corporation operates within the healthcare distribution sector, providing pharmaceuticals, medical supplies, and healthcare technology.,Institutional ownership plays a major role in the company’s market positioning and strategic d...

Why Did Erste Asset Management GmbH Reduce Its Holdings in CVS Health Co.?

March 16, 2025 10:14 AM PDT| By Team Kalkine Media

Highlights,Erste Asset Management GmbH significantly decreased its holdings in CVS Health Co.,(NYSE:CVS),during the fourth quarter.,Several institutional firms also adjusted their positions in the company over recent months.,Institutional ownership i...